1 - 5 out of 5Page size: 10
  1. 2022

  2. Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus

    BeNeDuctus Trial Investigators, 6 Dec 2022, In: The New England journal of medicine.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Amniotic Fluid: A Perspective on Promising Advances in the Prevention and Treatment of Necrotizing Enterocolitis

    de Kroon, R. R., de Baat, T., Senger, S. & van Weissenbruch, M. M., 14 Mar 2022, In: Frontiers in pediatrics. 10, 859805.

    Research output: Contribution to journal › Review article › Academic › peer-review

  4. Clinical predictors of bacteraemia in neonates with suspected early-onset sepsis in Malawi: A prospective cohort study

    de Baat, T., Lester, R., Ghambi, L., Twabi, H. H., Nielsen, M., Gordon, S. B., van Weissenbruch, M. M., Feasey, N. A., Dube, Q., Kawaza, K. & Iroh Tam, P-Y., 2022, (E-pub ahead of print) In: Archives of disease in childhood. archdischild-2022-324476.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. 2021

  6. Multi-centre, randomised non-inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (the BeNeDuctus trial): statistical analysis plan

    on behalf of the BeNeDuctus trial study group, 1 Dec 2021, In: Trials. 22, 1, 627.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. 2020

  8. Two Decades of Global Child Health at Amsterdam UMC

    Boele van Hensbroek, M., Smit, M. R., Brabin, B. J., Calis, J. C. J., van der Kuip, M., Meels, N., Nieuwenhuijs, L., Voskuijl, W. P., van Weissenbruch, M. M., van Woensel, J. B. M., de Baat, T., Huibers, M. H. W. & Tutu-van Furth, M. M., 30 Oct 2020, Amsterdam Centre for Global Child Health. 90 p.

    Research output: Book/Report › Report › Academic

ID: 48461